Treovir
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3675 Market St, Philadelphia, Pennsylvan...Website
www.treovir.comRevenue
<$5 MillionIndustry
About Treovir
Treovir Org Chart
Is Treovir your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Treovir is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Treovir launches new products
Earning: See what the market has to say on Treovir recently announced quarterly report
Funding: Get notified immidiatlly once Treovir has new funding data
Treovir, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Treovir had a recent Job posting/layoffs
Check if Treovir has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Treovir
Recommended Actions
Find VP level buyers at Treovir
Find 2 more new buyers
Compare Similar Companies to Treovir
Compare insights from companies similar to Treovir, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Treovir is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Treovir is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Treovir.
Treovir Tech Stack
A closer look at the technologies used by Treovir
Treovir News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Treovir
Treovir Inc. is focused on developing innovative therapies for pediatric brain tumors, specifically targeting the recurrent glioblastoma with their G207 Therapy. Their Phase 1 study has shown improved survival rates without serious side effects, addressing the urgent need for effective treatments in this area. The company aims to enhance the qualit... Read More